GMP/GLP Expertise Target pharmaceutical, biotech, and chemical companies seeking FDA-inspected, GMP/GLP compliant analytical testing and method development. Emphasize end-to-end USP testing capabilities and compliance to drive new lab partnerships.

Specialized USP Offerings Highlight capability in USP <232/233>, USP <281>, USP <467>, and elemental impurity testing to attract clients needing regulatory-grade impurity profiling, residual solvent analysis, and water content determination.

Global Requests Promote acceptance of both domestic and international requests to broaden market reach; leverage mentions of worldwide pharmaceutical and chemical clients to pursue global CRO collaborations and export opportunities.

Niche Technologies Leverage advanced tools (ICP-OES/ICP-MS, GC/GC-MS, HPLC, FTIR/NIR, DSC/TGA) to upsell comprehensive analytical packages, cross-sell method development/validation, and competitive differentiation against smaller labs.

Growth Readiness Encourage conversations around capacity and scalability for regulatory testing as revenue sits in the $1M–$10M range; position as a flexible partner capable of handling diverse project scopes for expanding client bases.